Maintenance Panitumumab Monotherapy Tested Against Combination with Fluorouracil-Leucovorin for Colorectal Cancer

Leggi l'articolo originale


The phase II study compared single-agent anti-EGFR panitumumab to panitumumab combined with fluorouracil-leucovorin in patients with RAS wild-type metastatic colorectal cancer.

Lascia un commento